Search research articles
Contact Us
Filters
Showing results (61-70 of 130) with videos related to
Page
of 13
Sort By:
The European Respiratory Journal
|
November 10, 2009
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
M R Partridge, M Miravitlles, E Ståhl, et al.
The European Respiratory Journal
|
January 24, 2009
Validation of the COPD severity score for use in primary care: the NEREA study
M Miravitlles, C Llor, R de Castellar, et al.
Respiration; International Review of Thoracic Diseases
|
November 9, 2000
Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group
M Miravitlles, T Guerrero, C Mayordomo, et al.
Thorax
|
August 25, 2006
Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics
D Soy, C de la Roza, B Lara, et al.
The European Respiratory Journal
|
June 1, 1997
Increased risk of tuberculosis transmission in families with microepidemics
R Vidal, M Miravitlles, J A Caylà, et al.
Respiratory Medicine
|
August 28, 1999
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo
M Miravitlles, C Mayordomo, M Artés, et al.
Medicina Clinica
|
July 7, 1990
[Familial microepidemics of tuberculosis]
R Vidal Pla, R Roca Tey, M Miravitlles, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1994
Scintigraphy, angiography and computed tomography in unilateral hyperlucent lung due to obliterative bronchiolitis
M Miravitlles, A Alvarez-Castells, R Vidal, et al.
Archivos De Bronconeumologia
|
December 1, 1994
[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]
M Miravitlles, R Vidal, M Torrella, et al.
Medicina Clinica
|
May 20, 1995
[IgG subclasses in patients with symptomatic IgA deficiency]
J de Gracia, M Miravitlles, M Vendrell, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 130) with videos related to
Sort By:
Page
of 13
The European Respiratory Journal
|
November 10, 2009
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
M R Partridge, M Miravitlles, E Ståhl, et al.
The European Respiratory Journal
|
January 24, 2009
Validation of the COPD severity score for use in primary care: the NEREA study
M Miravitlles, C Llor, R de Castellar, et al.
Respiration; International Review of Thoracic Diseases
|
November 9, 2000
Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group
M Miravitlles, T Guerrero, C Mayordomo, et al.
Thorax
|
August 25, 2006
Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics
D Soy, C de la Roza, B Lara, et al.
The European Respiratory Journal
|
June 1, 1997
Increased risk of tuberculosis transmission in families with microepidemics
R Vidal, M Miravitlles, J A Caylà, et al.
Respiratory Medicine
|
August 28, 1999
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo
M Miravitlles, C Mayordomo, M Artés, et al.
Medicina Clinica
|
July 7, 1990
[Familial microepidemics of tuberculosis]
R Vidal Pla, R Roca Tey, M Miravitlles, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1994
Scintigraphy, angiography and computed tomography in unilateral hyperlucent lung due to obliterative bronchiolitis
M Miravitlles, A Alvarez-Castells, R Vidal, et al.
Archivos De Bronconeumologia
|
December 1, 1994
[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]
M Miravitlles, R Vidal, M Torrella, et al.
Medicina Clinica
|
May 20, 1995
[IgG subclasses in patients with symptomatic IgA deficiency]
J de Gracia, M Miravitlles, M Vendrell, et al.
Page
of 13